- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Amneal Pharma starts commercial operations in India
Mumbai: Amneal Pharmaceuticals, Inc., has announced the launch of its commercial operations in India. To helm its India Commercial operations, Amneal has appointed Mr. Shyamakant Giri as Managing Director and President, India Business and Emerging Markets.
Mr. Giri has over two decades of experience leading business divisions and strategic operations of leading Indian and multinational organizations. In this new role, he will be responsible for Amneal's commercial expansion and growth in India, Africa, Gulf, CIS and South Asian markets.
Mr. Chirag and Chintu Patel, Co-Chief Executive Officers, Amneal said, "We are elated to be extending Amneal's operations in India - a place close to our hearts. We look forward to working with the Indian stakeholders to make healthy possible through increased access to the latest innovations in essential medicines. Being a community-oriented firm, we have placed a specific emphasis on innovating products that address the market's unmet needs. Onboarding an industry veteran like Giri, who shares our vision, will be a major impetus behind Amneal's growth in India."
Mr. Shyamakant Giri, Managing Director and President, India Business and Emerging Markets, Amneal Healthcare Pvt. Ltd., said, "I am honored to be a part of the Amneal family. A purpose driven company with a legacy of more than two decades, Amneal has been a rising leader in the U.S. pharmaceutical industry, and now is bringing access to global quality medical solutions in India today. With Amneal's 20+ year legacy of strong R&D, expansive portfolio and know how, I believe we can deliver substantial value in addressing the country's medical requirements and offer solutions to numerous health concerns."
"With the commencement of Amneal's India commercial operations, the company aims to serve the unmet medical needs, and extend its industry-leading reputation for high quality products at affordable prices," the company stated.
Read also: Amneal Pharma buys Punishka Healthcare for Rs 700 crore
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751